Risks - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Risks

Description:

Clinical Toxicology Department, Suez Canal University ... Use indwelling catheter rather than repeated veni-puncture for blood sampling. Protocol ... – PowerPoint PPT presentation

Number of Views:24
Avg rating:3.0/5.0
Slides: 34
Provided by: Nah73
Category:
Tags: puncture | risks

less

Transcript and Presenter's Notes

Title: Risks


1
Risks Benefits in Research Special Reference
to Pediatric Research
  • Nahed Moustafa, MD
  • Professor Head of Forensic Med. Clinical
    Toxicology Department, Suez Canal University
  • Certified Trainer of Research Ethics, Maryland
    University, USA

2
Agenda
  • Introduction
  • Historical examples of risky pediatric clinical
    research
  • Favorable risk- benefit ratio
  • Risks Components, Types, Grades, Minimization
  • Benefits
  • Minimization of risks in pediatric research.

3
Introduction
  • Research Ethics Committee (REC) is charged with
    mandate of protecting the rights and welfare of
    research subjects
  • REC spend
  • - much time reviewing
  • the informed consent
  • - little time analyzing
  • the risks potential benefits

4
Introduction-2
  • Because of childrens increased vulnerability,
    guidelines
  • requires the permission of a parent or legal
    guardian
  • strictly limits the research to which children
    may be exposed

5
Some Historical Examples
  • Willowbrook State Hospital for the Mentally
    Retarded (1950s 1960s)
  • Institutionalized children were purposefully
    infected with hepatitis virus to study the
    natural history and epidemiology of the disease
    in children

6
Favorable Risk-Benefit Ratio
  • Potential benefits are enhanced
  • Risks are identified and minimized
  • The potential benefits to individual subjects
    society are proportionate to or outweigh the
    risks

Justification Beneficence, Nonmaleficence, Non-ex
ploitation
Risk
Benefit
7
Risks To Whom?
To Society
To Subject
8
Risks Components
  • Magnitude of harm
  • Death
  • Slight discomfort
  • Probability of harm
  • - 1/ 1,000,000
  • - 1/ 10

9
Types of Risks
Physical
Social
Economic
Psychological
10
Types of Risks-2
  • Physical subjects may suffer bodily harm
  • minor or serious
  • temporary or permanent
  • immediate or delayed
  • Psychological
  • Survey research
  • Genetic testing
  • Social
  • breach of confidentiality
  • Stigma
  • Discrimination
  • Economic
  • Travel to clinic

11
Levels of risks
Minimal
Above minimal
Too risky
12
Levels of risks-2
  • Minimal risk The probability magnitude of
    harm or discomfort anticipated in the research
    are not greater in and of themselves than those
    ordinarily encountered in daily life or during
    the performance of routine physical or
    psychological examinations or tests

13
Levels of risks-2
  • Minimal Risk
  • Regulations do not index it to a particular
    pediatric population
  • Institute of Medicine Recommendations -- Minimal
    Risk
  • Normal experiences of average, healthy, normal
    children (absolute standard)

14
Levels of risks-3
  • Minimal risk is used as
  • 1-sorting mechanism directing the attention of
    REC to studies posing greater risks
  • 2- threshold limiting the amount of
    non-therapeutic risk to which vulnerable
    research subjects may be exposed

15
Levels of risks-4
  • Minimal risk may be age dependent
  • (blood draw may be minimal risk for an adult but
    not for a young child!!!)
  • Remember
  • The risks need not be physical in order to be
    greater than minimal risk
  • e.g., privacy confidentiality risks push the
    study into greater than minimal risk

16
Levels of risks-5
  • Minimal Risk
  • Seems to raise more questions than it answers!

17
Mimimization of Risk
  • Proper research design
  • Inclusion/exclusion criteria
  • exclude high risk/vulnerable subjects
  • Strict withdrawal criteria
  • Alternation in study design
  • Emergency medication
  • Availability of resources
  • (well equipped research center)
  • Confidentiality protections
  • Safety monitoring
  • Qualified personnel
  • Compensation provisions

18
Benefit to whom?
To Research Subject
To Society
19
Benefits to Research Subjects
  • Direct Benefit
  • arising from the intervention being studied
  • information that can influence care
  • Collateral Benefit
  • Also called indirect benefit
  • access to medical care not available for economic
    reasons
  • Inspirational
  • Altruism
  • Aspirational
  • benefit to society (arises from the results of
    the study)

20
Benefits to Research Subjects-2
  • Payments or incentives benefits???
  • Should not be considered as benefits in the
    calculation of risk/benefit ratio
  • REASON Any level of research risk could be
    offset by such gains if they were significant
    enough

21
We have to avoid
Undue-inducement
coercion
22
Benefits to Research Subjects-2
  • No benefits from the research
  • Phase I trials that are testing maximum tolerated
    dose
  • Non-therapeutic research procedures
  • e.g., Mechanism of disease

23
Benefits to Society
  • Specific new, effective intervention
  • Post-trial availability
  • Knowledge which sometimes in the future may lead
    to effective interventions

24
Risk Judgments in vulnerable populations
  • Persons incapable of giving informed consent
  • Patients with psychiatric illnesses
  • Patients with dementia
  • Patients with acute critical illnesses
  • Children

25
Minimization of risks in pediatric research
  • REC that regularly reviews pediatric research
    should include one or more individuals who are
    knowledgeable in pediatric ethical, clinical and
    psychological issues

26
Minimization of risks in pediatric research-2
  • REC should consider the risks from the childs
    perspective not simply focus on physical and
    economic risks.
  • For example the research area should be child
    friendly i.e. has a space for parents to remain
    with the child

27
Minimization of risks in pediatric research-3
  • REC should approve the research design that
    minimizes the risks, e.g.,
  • A protocol that can not answer the research
    question should not be approved
  • A sample size that exceeds the number of children
    necessary to answer the research question expose
    additional children to unnecessary risks, should
    not be approved

28
Minimization of risks in pediatric research-4
  • 3- A pediatric trial requires different efficacy
    endpoints based on considerations of age
    development of the subjects
  • 4- A pediatric trial may need to evaluate any
    adverse impact on
  • physical cognitive
  • growth development

29
Minimization of risks in pediatric research-5
  • Minimizing discomfort distress
  • Skillful persons
  • Play equipments
  • Food appropriate for age
  • A familiar environment in which he usually has
    his care hospital or clinic
  • Minimizing the blood volume withdrawn through the
    use of sensitive assays
  • Use indwelling catheter rather than repeated
    veni-puncture for blood sampling

30
RiskBenefit Determination Vulnerable Subjects
Protocol
Non-Therapeutic Procedures
Therapeutic Procedures
Risks Identified Risks Minimized
Risks Identified Risks Minimized Test of
Clinical Equipoise
Risks Reasonable to Knowledge to be Gained
Risks Reasonable to Benefits
Maximum Risk Threshold No More Than Minor
Increase gt Minimal Risk
Acceptable Only If For Both Therapeutic/
Non-Therapeutic Procedures
31
  • The previous slide quoted from
  • Weijer, C. (2000) The ethical analysis of risk.
    Journal of Law, Medicine and Ethics, 28 344-361

32
Remember
  • Trust
  • can take years to build and a moment to break

33
Thank you
nmoustafa2004_at_yahoo.com
Write a Comment
User Comments (0)
About PowerShow.com